ClassID:

96981

C07K14/575 - page 4 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Hormones

Recent Application in this class:
#901
20070014736
2007-01-18

Methods of delivering corticotroph-derived glycoprotein hormone

#902
20070009908
2007-01-11

Human stanniocalcin-alpha

#903
20070004630
2007-01-04

Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology

#904
20060293499
2006-12-28

Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates

#905
20060293232
2006-12-28

Hybrid polypeptides having glucose lowering activity

#906
20060293221
2006-12-28

Mucosal repair by TFF2 peptides

#907
20060276626
2006-12-07

Methods for the production of peptide derivatives

#908
20060276586
2006-12-07

Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof

#909
20060276396
2006-12-07

Albumin fusion proteins

#910
20060234947
2006-10-19

Peptides directed for diagnosis and treatment of amyloid-associated disease

#911
20060229241
2006-10-12

Hypoxia induced mitogenic factor

#912
20060211610
2006-09-21

Peptide YY analogs

#913
20060199948
2006-09-07

Method for improving recovery yield in protein purification with gel filtration chromatography

#914
20060194735
2006-08-31

Albumin fusion proteins

#915
20060188513
2006-08-24

Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians

#916
20060178501
2006-08-10

PYY agonists and use thereof

#917
20060172391
2006-08-03

BMP-11 compositions

#918
20060162026
2006-07-20

Expressing TGF-beta proteins in plant plastids

#919
20060160742
2006-07-20

Neuropeptide-2 receptor (Y-2R) agonists and uses thereof

#920
20060160730
2006-07-20

Compositions and methods for promoting angiogenesis

#921
20060154331
2006-07-13

Erythrocyte differentiation factor, gene encoding same, and methods of use thereof

#922
20060148699
2006-07-06

Counterion exchange process for peptides

#923
20060135747
2006-06-22

Pancreatic polypeptide family motifs, polypeptides and methods comprising the same

#924
20060122106
2006-06-08

Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof

#925
20060115874
2006-06-01

Enrichment method for variant proteins with altered binding properties

#926
20060111278
2006-05-25

TFF peptides

#927
20060110771
2006-05-25

Proteins capable of binding to female sex hormones and process for producing the same

#928
20060105429
2006-05-18

Fusion polypeptides of human serum albumin and a therapeutically active polypeptide

#929
20060099571
2006-05-11

Stabilized bioactive peptides and methods of identification, synthesis, and use

#930
20060094679
2006-05-04

Method of preventing or treating liver disease

#931
20060094653
2006-05-04

Pancreatic polypeptide family motifs and polypeptides comprising the same

#932
20060094652
2006-05-04

Hybrid polypeptides with selectable properties

#933
20060084597
2006-04-20

USE OF COMPOUNDS HAVING GIP ACTIVITY FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH ABNORMAL LOSS OF CELLS AND/OR FOR THE TREATMENT OF OBESITY

#934
20060073567
2006-04-06

Antibodies to insulin/IGF/relaxin family polypeptides

#935
20060063716
2006-03-23

Intermedin and its uses

#936
20060063699
2006-03-23

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

#937
20060062788
2006-03-23

Method for determining MIF content

#938
20060059578
2006-03-16

Adiponectin-knoucout nonhuman animal

#939
20060057664
2006-03-16

Polypeptides and polynucleotides encoding same

#940
20060057152
2006-03-16

Helicobacter system and uses thereof

#941
20060052301
2006-03-09

Splice variants of peptide YY, neuropeptide Y, pancreatic peptide Y and Amylin, and uses thereof

#942
20060047107
2006-03-02

Cortistatin: neuropeptides, compositions and methods

#943
20060040859
2006-02-23

Peptides, DNAs, RNAs, and compounds for inhibiting or inducing adrenomedullin activity, and use of the same

#944
20060024750
2006-02-02

Methods of identifying modulators of ligand binding to ChemerinR polypeptides

#945
20060020116
2006-01-26

Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules

#946
20060019881
2006-01-26

Human spasmolytic polypeptide in glycosylated form

#947
20060019347
2006-01-26

Biosynthetic polypeptides utilizing non-naturally encoded amino acids

#948
20050287640
2005-12-29

Human spasmolytic polypeptide in glycosylated form

#949
20050282255
2005-12-22

Monomeric protein of the TGF-β family

#950
20050277590
2005-12-15

Analogs of gastric inhibitory polypeptide and their use of treatment for diabetes

#951
20050272652
2005-12-08

Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity

#952
20050272648
2005-12-08

Ghrelin analogs

#953
20050266519
2005-12-01

Methods and compositions for modulating and detecting activin dimer and dimer formation

#954
20050256302
2005-11-17

Novel peptides having camp producing activity

#955
20050255573
2005-11-17

Pluripotency determining factors and uses thereof

#956
20050250185
2005-11-10

OGH fusion polypeptides and therapeutic uses thereof

#957
20050250184
2005-11-10

Peptide hormones zalpha48 and zsig97

#958
20050249734
2005-11-10

Cortistatin: neuropeptides, compositions and methods

#959
20050245441
2005-11-03

Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity

#960
20050239167
2005-10-27

Methods of treatment with interferson and albumin fusion protein

#961
20050220762
2005-10-06

Modified human interferon polypeptides and their uses

#962
20050208626
2005-09-22

SGIP peptides

#963
20050208569
2005-09-22

Human stanniocalcin-alpha

#964
20050208552
2005-09-22

Methods for detecting Corpuscles of Stannius protein stanniocalcin

#965
20050203003
2005-09-15

Contulakin-G, analogs thereof and uses therefor

#966
20050186664
2005-08-25

Albumin fusion proteins comprising GLP-1 polypeptides

#967
20050186212
2005-08-25

Trefoil factor 3 (TFF3) as a target for anti-cancer therapy

#968
20050180949
2005-08-18

hC1Q/TNF7 and uses thereof

#969
20050171007
2005-08-04

Therapeutic method

#970
20050170461
2005-08-04

Polypeptides, their production and use

#971
20050170404
2005-08-04

Human growth hormone modified at position 35

#972
20050164914
2005-07-28

Metallopeptide compositions for treatment of sexual dysfunction

#973
20050155090
2005-07-14

Monoclonal antibodies that bind Chemerin polypeptide

#974
20050153374
2005-07-14

Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes

#975
20050148511
2005-07-07

FGF variants and methods for use thereof

#976
20050132969
2005-06-23

Inducing sterility in fish by disrupting the development of the GnRH system

#977
20050129617
2005-06-16

Type1 diabetes diagnostics and therapeutics

#978
20050106146
2005-05-19

Antibodies to motilin homologs

#979
20050095676
2005-05-05

Novel glycoproteins and methods of use thereof

#980
20050089852
2005-04-28

Method and compositions for evaluating risk of developing type 2 diabetes in people of chinese descent

#981
20050069914
2005-03-31

Novel glycoproteins and methods of use thereof

#982
20050059605
2005-03-17

Chemically modified metabolites of regulatory peptides and methods of producing and using same

#983
20050059120
2005-03-17

Compositions, methods, and kits relating to resistin-like molecules

#984
20050059011
2005-03-17

Amplification and overexpression of oncogenes

#985
20050049177
2005-03-03

Stable analogs of peptide and polypeptide therapeutics

#986
20050048618
2005-03-03

Zsig33-like peptides and polynucleotides

#987
20050043520
2005-02-24

Antibodies to PRO1410

#988
20050043237
2005-02-24

Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use

#989
20050026829
2005-02-03

Methods and compositions for selective modulation of vascularization

#990
20050026247
2005-02-03

Process for preparing purified active monomer of bone-derived factor

#991
20050020497
2005-01-27

Mammalian glycoprotein hormone-1

#992
20050020492
2005-01-27

Selective melanin-concentrating hormone type-1 receptor agonists

#993
20050014187
2005-01-20

Polypeptide hormone phosphatonin

#994
20050003491
2005-01-06

Secreted proteins and polynucleotides encoding them